Identifying predictive markers for CLL
Current and potential PI3K and BTK inhibitors for CLL
The importance of the collaboration of the solid and liquid tumor communities
How far are we from a cure for CLL?
Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.